(Reuters) -Drugmaker Eli Lilly is in advanced talks to acquire gene-editing startup Verve Therapeutics for up to $1.3 billion ...

HHS Secretary Robert F. Kennedy Jr. places anti-vaxxers in control of U.S. vaccine policy, slandering an actual expert along ...

The budget cuts threaten global progress on everything from heart disease to H.I.V. — and could affect American drug ...

The IPO comes just a few weeks after Caris raised $168 million in a private financing round that took the total raised by the ...

The US Supreme Court on Monday declined to review a federal appeals court decision that Merck Sharpe & Dohme Corp. couldn’t ...

That challenge, of finding or building good, useable data sets, is also one of the biggest differentiators in an increasingly ...

Artificial intelligence (AI) is no longer a distant innovation — it's now a core part of the pharmaceutical and life sciences ...

A Roots Analysis study showed the market for ADC manufacturing is $1.79 billion today, but is expected to grow to $7 billion ...

AQR Capital's Q1'25 portfolio hits $97.07B, with top picks in AAPL, NVDA, & AMZN. Active portfolio adjustments show a ...

Merck ( MRK) is a global biopharmaceutical giant with a diversified portfolio that spans across oncology, vaccines, ...

ANGLE presents new data at EACR 2025 DEMONSTRATING DNA DUAL ANALYSIS FOR COMPREHENSIVE LIQUID BIOPSY PROFILING Poster highlights ANGLE's combined CTC-DNA and ctDNA analysis revealing tumour ...

All-time great Eddy Merckx has said that were he racing today, his ideal squad would be UAE Team Emirates-XRG.